CDXS Logo 2 April 2021.jpg
Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 23, 2023 16:06 ET | Codexis, Inc.
Biotherapeutics Application of CodeEvolver® Validated by Recent Data Supporting the Potential for Three Upcoming Investigational New Drug Applications Cash Runway Through End of 2024 Funds Important...
CDXS Logo 2 April 2021.jpg
Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency
February 23, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, and Nestlé Health Science, a leader in the science of nutrition, today...
CDXS Logo 2 April 2021.jpg
Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium™
February 22, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today highlights several key presentations from its gene therapy programs...
CDXS Logo 2 April 2021.jpg
Codexis Announces New Employment Inducement Grants
February 15, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the grant of an inducement award to the Company’s recently...
CDXS Logo 2 April 2021.jpg
Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23
February 09, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the fourth...
CDXS Logo 2 April 2021.jpg
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
January 23, 2023 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer...
CDXS Logo 2 April 2021.jpg
Codexis Announces Appointment of H. Stewart Parker to Board of Directors
December 20, 2022 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of...
CDXS Logo 2 April 2021.jpg
Codexis Provides Update on Prioritized Corporate Strategy
November 29, 2022 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its...
CDXS Logo 2 April 2021.jpg
Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference
November 16, 2022 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...
CDXS Logo 2 April 2021.jpg
Codexis to Participate in Upcoming Healthcare Conferences
November 08, 2022 16:05 ET | Codexis, Inc.
REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that management...